Wuhan Wansheng Biotechnology
GHK-Cu
Finnrick tested 8 samples of GHK-Cu from Wuhan Wansheng Biotechnology between 4 Aug 2025 and 6 Dec 2025. Test scores average over 5, no score below 4, and at least 6 tests warrant a confident Finnrick Rating of C (Okay).
Finnrick Rating™
Wuhan Wansheng Biotechnology
GHK-Cu
Tested 8 Samples
Last test 6 Dec 2025
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other GHK-Cu tests from top-rated vendors:
All GHK-Cu tests from Wuhan Wansheng Biotechnology
Samples are tested in commercial labs
Tests Count
8
Scores
AVGMINMAX
Last
6 Dec 2025
First
4 Aug 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 6 Dec 2025 | View | 50mg | 53.4mg | +6.8% | 99.95% | WWB 11/2025 | White Label / Silver Crimp / White Cap | Lab E | Public | |
| 27 Oct 2025 | View | 50mg | 60.63mg | +21.3% | 99.98% | (no batch ID) | White Label / Copper Crimp / Clear Cap | Lab A | Public | |
| 23 Oct 2025 | View | 50mg | 35.3mg | -29.4% | 99.90% | (no batch ID) | No Label / Silver Crimp / White Cap | Lab E | Public | |
| 21 Oct 2025 | View | 50mg | 43.3mg | -13.4% | 99.95% | (no batch ID) | No Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 21 Oct 2025 | View | 100mg | 107mg | +7.0% | 99.95% | (no batch ID) | No Label / Silver Crimp / Clear Cap | Lab E | Public | |
| 9 Oct 2025 | View | 100mg | 56.7mg | -43.3% | 99.95% | (no batch ID) | No Label / Silver Crimp / Violet Cap | Lab E | Public | |
| 25 Sep 2025 | View | 50mg | 51.6mg | +3.2% | 99.95% | 07-2025 | No Label / Silver Crimp / White Cap | Lab E | Public | |
| 4 Aug 2025 | View | 50mg | 52.5mg | +5.0% | 99.84% | WWB-0830 | White Label / Silver Crimp / Violet Cap | Lab E | Public | |